DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development

CUPERTINO, Calif., Sept. 20, 2017 -- (Healthcare Sales & Marketing Network) -- DURECT Corporation (Nasdaq: DRRX) announced today that Dr. Myriam Theeuwes has joined DURECT as Senior Vice President, Clinical Development. Dr. Theeuwes joins DURECT from Joh... Biopharmaceuticals, Personnel DURECT, Epigenetic Regulator, nonalcoholic steatohepatitis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news